During the past decade, Centro de Diagnostico Cardiologico LTDA. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Diagnostico Cardiologico LTDA." #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centro de Diagnostico Cardiologico LTDA." are "Cardiovascular Disease" (2 trials), "Heart Failure" (1 trials), "Hyperlipidemia" (1 trials) and "Venous Thromboembolism" (1 trials). Many other conditions were trialed in "Centro de Diagnostico Cardiologico LTDA." in a lesser frequency.

Most popular intervention types in "Centro de Diagnostico Cardiologico LTDA." are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "bococizumab (PF-04950615)" (2 trials), "Bococizumab (PF-04950615; RN316)" (1 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Diagnostico Cardiologico LTDA." are 5 trials for "All" genders.

Currently, there are NaN active trials in "Centro de Diagnostico Cardiologico LTDA.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Centro de Diagnostico Cardiologico LTDA., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Diagnostico Cardiologico LTDA., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".